CHEMICON International, Inc. has been in operation
since 1981, supplying immunological reagents to the biomedical
research community. In 1992, CHEMICON expanded into the area of
diagnostic kits and reagents by supplying immunodiagnostic products
for antigen detection of infectious disease. CHEMICON recently
launched a line of molecular biology products designed for research
and clinical applications. Our mission is to provide quality products
and services to advance science within the research, diagnostic
and the pharmaceutical communities.
CHEMICON develops, manufactures, markets, and distributes over
6,000 products spanning many scientific disciplines including
Neuroscience, Adhesion, Apoptosis, Cell Signaling and Infectious
Disease. In addition, CHEMICON has developed a diverse portfolio
of proprietary technologies including a method for making fusion
proteins (GST), Leukemia Inhibitory Factor (LIF), and Bioluminescence
Proteins.
CHEMICON has experienced consistent growth over the past 20
years. The company currently employs over 200 professionals
ranging from laboratory technicians to Ph.D. scientists and
business personnel. The new corporate facility located in Temecula,
California consists of 84,700 square feet and maintains the
central operation including R&D, Manufacturing, Operations,
Sales, Marketing, and Administration.
CHEMICON International, Inc. markets its products with a direct
sales team in North America and through a network of distributors
throughout the world. CHEMICON has expanded its physical operations
and maintains state-of-the-art cGMP certified, TGA and ISO approved
custom manufacturing facilities in the United States, Australia,
and the United Kingdom.
